Vasculitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Little is known about the role of adenosine deaminase (ADA) 2 in regulation of immune responses, although recent reports linked ADA2 deficiency with inflammation and vasculitis.
|
26607704 |
2016 |
Esophageal Atresia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We propose to consider a role for selected genes such as AATF (cell proliferation and apoptosis) and TADA2L (Wnt pathway) at the 17q12 region as well as developmental and transcriptional pathways represented by these genes, in the development of OA/TOF and VATER association.
|
24239950 |
2014 |
Tetralogy of Fallot
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We propose to consider a role for selected genes such as AATF (cell proliferation and apoptosis) and TADA2L (Wnt pathway) at the 17q12 region as well as developmental and transcriptional pathways represented by these genes, in the development of OA/TOF and VATER association.
|
24239950 |
2014 |
VATER Association
|
0.010 |
Biomarker
|
disease |
BEFREE |
We propose to consider a role for selected genes such as AATF (cell proliferation and apoptosis) and TADA2L (Wnt pathway) at the 17q12 region as well as developmental and transcriptional pathways represented by these genes, in the development of OA/TOF and VATER association.
|
24239950 |
2014 |
VACTERL Association
|
0.010 |
Biomarker
|
disease |
BEFREE |
We propose to consider a role for selected genes such as AATF (cell proliferation and apoptosis) and TADA2L (Wnt pathway) at the 17q12 region as well as developmental and transcriptional pathways represented by these genes, in the development of OA/TOF and VATER association.
|
24239950 |
2014 |
Malignant tumor of colon
|
0.010 |
Biomarker
|
disease |
BEFREE |
In colon cancer ADA₁*2/ADA₂*1 haplotype is more represented, while ADA₁*2/ADA₂*2 is less represented than in controls.
|
20590444 |
2010 |
Colon Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In colon cancer ADA₁*2/ADA₂*1 haplotype is more represented, while ADA₁*2/ADA₂*2 is less represented than in controls.
|
20590444 |
2010 |
Coronary Arteriosclerosis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
ADA*2 allele of the adenosine deaminase gene may protect against coronary artery disease.
|
17287605 |
2007 |
Coronary heart disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
ADA*2 allele of the adenosine deaminase gene may protect against coronary artery disease.
|
17287605 |
2007 |
Coronary Artery Disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
ADA*2 allele may decrease genetic susceptibility to CAD.
|
17287605 |
2007 |
Asthma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our data suggest the presence of some DNA sequences influencing the susceptibility to asthma are located in the area between ADA(1) and ADA(2) sites.
|
16754522 |
2006 |
Severe intellectual disability
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Cases (ie, 80 children) were more likely than controls (ie, 153 healthy children and 105 children with moderate or severe mental retardation) to have the low-activity ADA-Asn 8 (ADA(1) *2) polymorphism (P < .05) and to present the ADA(1) *2/ ADA(2) *1 haplotype.
|
16970880 |
2006 |
Malaria
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
In Sardinia, the frequency of the *L(M)/ADA*2 gametic type is negatively correlated with past malarial endemia, suggesting an increased susceptibility to malaria leading to its decrease in areas with high malarial endemia.
|
15761857 |
2005 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Since the activity of genotypes carrying the ADA*2 allele is lower than that of the more common genotype ADA*1/*1, genetic variability of the enzyme could contribute to degree of obesity in NIDDM.
|
10459555 |
1999 |
Obesity
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Since the activity of genotypes carrying the ADA*2 allele is lower than that of the more common genotype ADA*1/*1, genetic variability of the enzyme could contribute to degree of obesity in NIDDM.
|
10459555 |
1999 |